Our previous meetings have consistently delivered insightful and valuable content. We are pleased to welcome you to the 5th Global IDMP Working Group (GIDWG) Stakeholder Public Day Meeting, scheduled for 3 October 2025, and graciously hosted by the European Medicines Agency in Amsterdam, the Netherlands.
Presentation materials:
The Global IDMP Working Group (GIDWG), is pleased to invite you to an online public meeting, streaming live from the European Medicines Agency (EMA) on Friday 3th October 2025 at 12:30 to 14:00 CEST via Zoom.
This year’s GIDWG Stakeholder Public Meeting will present important updates and insights from the Global IDMP Working Group. The co-chairs will highlight key takeaways from the recent technical meeting, followed by contributions from GIDWG members showcasing their involvement in IDMP and use case opportunities for Global PhPID Services
All interested stakeholders are welcome to attend the meeting and engage with this pivotal effort to strengthen global medicinal product data standards.
To register, please visit https://who-umc-org.zoom.us/webinar/register/WN_XTv5y_HpSUmDya9Z5TwodA
This document provides high-level guidance and recommendations from the Global IDMP Working Group (GIDWG) on how to assign Pharmaceutical Product Identifiers (PhPIDs) to marketed medicinal products for human use. It is regularly updated as projects progress.
Our past conferences have been full of valuable information and great networking opportunities. We expect this year to be the same. Welcome to our 4th Global IDMP Working Group (GIDWG) Stakeholder Meeting, planned for the third week of September 2024, hosted by the Brazilian Health Regulatory Agency (Anvisa) in Brazil.
UPDATE: Thank you to everyone who attended the 4th GIDWG Technical and Stakeholder Meeting for making it such a success. It provided an excellent platform to further our shared vision of global IDMP implementation.
Presentations materials:
Testing of use cases for PhPID operating model
PURPOSE
To test the framework, including business rules, best practices, software, and operating model, for global IDMP implementation and maintenance of global identifiers for marketed products.
SCOPE
• Validate and generate PhPIDs for medicinal products based on GIDWG/EWG Business Rules
• EDQM and non-EDQM countries
• Similar products from different countries
• Larger batches and smaller data sets for regulators
• Test use cases for pharmacovigilance, drug shortages, and cross-border healthcare
STATUS
Completed
Global IDMP PhPID End-to-End Testing report, 5 December 2024
This workshop will bring together experts involved in various aspects of IDMP implementation worldwide, from product development to regulatory processes, clinical use, and outcome assessments.
Welcome to our 3rd Global IDMP Working Group (GIDWG) Stakeholder Meeting.
GIDWG’s mission is to establish a framework for global implementation of ISO IDMP standards and maintenance of global identifiers.
The GIDWG will report on 5 pilot projects:
These projects cover global use cases including pharmacovigilance, drug shortages, and cross-border healthcare.
Presentation materials:
Uppsala Monitoring Centre (UMC) sees IDMP as a game-changer for pharmacovigilance. It establishes a common language and enables the effective exchange of vital medicinal product data throughout the drug development and regulatory lifecycle. By standardising data exchange, IDMP improves our ability to identify, evaluate, and manage risks associated with medicinal products. In a one-hour webinar on 14 June 2023, UMC will discuss the current status of IDMP and collaboration efforts to implement the standards.
UPDATE: Recordings of the webinar are now available:
The IDMP standards aim to harmonise how pharmaceutical products and substances are described globally. But how will that benefit patients and who will make sure the standards are properly implemented? Uppsala Monitoring Centre’s Malin Fladvad and Olle Lagerlund discuss the advantages and challenges of this global standardisation effort in the Drug Safety Matters podcast.
From 23-25 October 2023, UNICOM will present the results of work package 2 related to substances. For more details, see the UNICOM website.